Latest Breaking News On - Nicolas lanthier - Page 1 : comparemela.com

INVENTIVA: The New England Journal of Medicine publishes the results of the NATIVE Phase IIb clinical trial with lanifibranor in NASH

In the Phase IIb NATIVE, lanifibranor met both the primary and key secondary endpoints, including NASH resolution with no worsening of fibrosis and improvement of liver fibrosis with no worsening of NASHNATIVE

New yorkUnited statesLyudmila matevaRohit loombaNicolas lanthierSven francqueStephena harrisonLuisa vonghiaMarie paule richardDiana stefanova petrovaManalf abdelmalekYannick tetzlaffMartine baudinArunj sanyalNaim alkhouriAude lepreux

Investegate |INVENTIVA Announcements | INVENTIVA: The New England Journal of Medicine publishes the results of the NATIVE Phase IIb clinical trial with lanifibranor in NASH

Investegate |INVENTIVA Announcements | INVENTIVA: The New England Journal of Medicine publishes the results of the NATIVE Phase IIb clinical trial with lanifibranor in NASH
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesLyudmila matevaRohit loombaNicolas lanthierSven francqueStephena harrisonLuisa vonghiaMarie paule richardDiana stefanova petrovaManalf abdelmalekYannick tetzlaffMartine baudinArunj sanyalNaim alkhouriAude lepreux

The New England Journal of Medicine publishes the results of the NATIVE Phase IIb clinical

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

New yorkUnited statesLyudmila matevaRohit loombaNicolas lanthierSven francqueStephena harrisonLuisa vonghiaMarie paule richardDiana stefanova petrovaManalf abdelmalekYannick tetzlaffMartine baudinArunj sanyalNaim alkhouriAude lepreux